Related Experiment Video
Updated: Oct 4, 2026

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Mechanism of atrial natriuretic factor-induced inhibition of rat mesangial cell mitogenesis
1Department of Medicine, School of Medicine, East Carolina University, Greenville 27858.
Abstract:
Recent observations suggest that atrial natriuretic factor (ANF) may have growth-inhibitory activity. The present studies were performed to further define this action in rat mesangial cells (which have both biological and clearance ANF receptors) and in 3T3 fibroblasts (which have only clearance ANF receptors). Both cell types were made quiescent by removal of serum and then reactivated by exposure to a serum-free defined medium. ANF inhibited [3H]thymidine uptake in a dose-dependent manner in mesangial cells (half-maximal response 10(-11) M; 47% maximal inhibitory effect) but had no effect in 3T3 fibroblasts. Exogenous 8-bromoguanosine 3',5'-cyclic monophosphate (0.1 mM) inhibited [3H]thymidine uptake by 33% in mesangial cells but had no effect in 3T3 fibroblasts. Counts in mesangial cells exposed to 0.1 mM sodium nitroprusside, which stimulates guanosine 3',5'-cyclic monophosphate (cGMP), were inhibited by 76%. However, this represented a toxic effect, because excessive trypan blue uptake was noted in this condition. Mesangial cell number after 3 days of logarithmic proliferation was reduced by 33% in cells incubated with 1.0 nM ANF compared with vehicle. Incubation of mesangial cell monolayers with ANF caused a concentration-dependent increase in intracellular cGMP accumulation. Threshold responses occurred at concentrations one order of magnitude greater than that resulting in the antimitogenic action. In 3T3 fibroblast monolayers exposed to ANF, cGMP accumulation occurred but was markedly attenuated compared with mesangial cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Atrial natriuretic factor (ANF) inhibits rat mesangial cell growth by affecting cyclic guanosine monophosphate (cGMP) signaling. This growth inhibition was observed in mesangial cells but not in 3T3 fibroblasts, indicating cell-specific responses to ANF.
Area of Science:
- Cell Biology
- Endocrinology
- Molecular Biology
Background:
- Atrial natriuretic factor (ANF) is increasingly recognized for potential growth-regulatory roles.
- Rat mesangial cells possess both biological and clearance ANF receptors, while 3T3 fibroblasts primarily have clearance receptors.
Purpose of the Study:
- To investigate the growth-inhibitory effects of ANF on rat mesangial cells and 3T3 fibroblasts.
- To elucidate the role of cyclic guanosine monophosphate (cGMP) in mediating ANF's cellular actions.
Main Methods:
- Quiescent rat mesangial cells and 3T3 fibroblasts were stimulated with serum-free medium.
- Inhibition of [3H]thymidine uptake was measured to assess DNA synthesis.
- Intracellular cGMP levels were quantified following ANF stimulation.
- Cell proliferation was assessed by counting cell numbers over time.
Main Results:
- ANF dose-dependently inhibited [3H]thymidine uptake in mesangial cells but not in 3T3 fibroblasts.
- Exogenous cGMP mimicked ANF's inhibitory effect in mesangial cells.
- ANF induced a concentration-dependent increase in intracellular cGMP in mesangial cells.
- Mesangial cell number was reduced by 33% with ANF treatment, while cGMP accumulation was attenuated in 3T3 fibroblasts.
Conclusions:
- ANF exhibits potent antimitogenic activity specifically in rat mesangial cells.
- cGMP signaling is implicated in the growth-inhibitory effects of ANF in mesangial cells.
- The differential response suggests a role for biological ANF receptors in mediating these effects.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Heart Failure II: Pathophysiology

